Results

eNauka >  Results >  Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Naziv: Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Autori: Verschraegen, Claire; Andric, Zoran G  ; Moiseenko, Fedor; Makharadze, Tamta; Shevnya, Sergii; Oleksiienko, Alona; Ruiz, Eduardo Yanez; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong;
Park, Sijin; Ju, Hana; Ohe, Yuichiro;
Godina: 2022
Publikacija: BIODRUGS
ISSN: 1173-8804 Biodrugs Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 36 br. 6 str. 749-760
DOI: 10.1007/s40259-022-00552-8
WoS-ID: 000861173900001
Scopus-ID: 2-s2.0-85139164272
PMID: 36169807
PMCID: PMC9649513
URI: https://enauka.gov.rs/handle/123456789/802450
Projekat: Celltrion, Inc. (Incheon, Republic of Korea)
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

11
SCOPUSTM
6
PubMed CentralTM
10
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.